Quoin Pharmaceuticals (QNRX)

• Market cap: $9.92M
• 1 day: 0%
• 5 days: 0.41%
• 1 month: -16.69%
• 3 months: -42.02%
• 6 months: -74.48%
• Year to date: -64.91%
• 1 year: -45.53%
• 5 years: -99.99%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Employees: 6